Evidence map›Paper›PMID 41148410›Full record

ArticleAIDS and behavior2026

Resilience to Stigma in Medical, Social, and Employment Contexts Among People Who Inject Drugs in Rural Ohio: Adapting the 10-Item Connor-Davidson Resilience Scale.

Madison N Enderle, Rebecca H Neiberg, Stacy M Endres-Dighe, Nisha Gottfredson O'Shea, Vivian F Go, William C Miller, Kathryn E Lancaster

Abstract read
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Madison N EnderleDivision of Public Health Sciences, Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA. menderle@wakehealth.edu.ORCID http://orcid.org/0000-0002-2592-0781
Rebecca H NeibergDivision of Public Health Sciences, Department of Biostatistics and Data Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
Stacy M Endres-DigheDivision of Epidemiology, College of Public Health, The Ohio State University, Columbus, OH, USA.
Nisha Gottfredson O'SheaDivision of Behavioral Health and Wellbeing, RTI International, Research Triangle Park (RTP), NC, USA.ORCID http://orcid.org/0000-0002-4765-7179
Vivian F GoDepartment of Health Behavior, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
William C MillerDepartment of Epidemiology, Gillings School of Global Public Health, The University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Kathryn E LancasterDivision of Public Health Sciences, Department of Implementation Science, Wake Forest University School of Medicine, Winston-Salem, NC, USA.ORCID http://orcid.org/0000-0003-2389-6973

Funding

The role of injection partnerships and preferences for reducing HCV risk: Giving a voice to young women in rural Appalachia.K01DA048174 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI LANCASTER, KATHRYN ELIZABETH · 2019 to 2023
$841k
Measuring resilience to intersectional stigma for people who inject drugs in need of HIV preventionR21DA053708 · NIDA · OHIO STATE UNIVERSITY · PI NORRIS, ALISON H · 2021 to 2022
$446k
Examining the mediating effect of resilience on intersectional stigma and HIV prevention among people who inject drugs in rural Appalachia OhioR36DA060059 · NIDA · OHIO STATE UNIVERSITY · PI ENDRES-DIGHE, STACY M. · 2023 to 2023
$53k
NIDA NIH HHS K01 DA048174NIDA NIH HHS R21 DA053708NIDA NIH HHS R36 DA060059
6 · The paper itself

Abstract

People who inject drugs (PWID) experience stigma related to drug use and HIV prevention, which can impede engagement with the HIV prevention continuum. Resilience may buffer against stigma's harmful effects, but limited research has examined how resilience operates across different social contexts and stigma types among PWID. Using qualitative interviews and cognitive interviews, we adapted the 10-item Connor-Davidson Resilience Scale to measure resilience to drug use-related stigma and HIV prevention-related stigma among PWID in rural Appalachian Ohio in three contexts: medical, social, and employment. To validate the scale adaptations, we administered a quantitative survey. We assessed internal consistency using Cronbach's alpha and fit Poisson regression models to test the association between high resilience and pre-exposure prophylaxis (PrEP) awareness and overdose response training. Among the 250 PWID who completed the quantitative survey, the six resilience scales demonstrated strong internal consistency. Examining frequency distributions, Bland-Altman plots, and factor analysis, we found the resilience responses varied by stigma type and context. Results of regression models indicated high resilience to HIV prevention-related stigma in the medical context was associated with PrEP awareness (adjusted prevalence ratio [aPR]: 1.37; 95% CI 1.05, 1.80) and overdose response training (aPR: 1.31; 95% CI 1.07, 1.61). Our study provides a novel approach to measuring context-specific resilience to stigma among PWID. Findings highlight the importance of tailoring interventions to both individual resilience and structural stigma, particularly in medical settings. Enhancing resilience and reducing stigma may support greater engagement with HIV prevention and harm reduction services in rural communities.

Indexed as

Drug UsersHIV InfectionsResilience, PsychologicalSocial StigmaSubstance Abuse, IntravenousAdultEmploymentFemaleHumansInterviews as TopicMaleMiddle AgedOhioPre-Exposure ProphylaxisPsychological TestsQualitative ResearchHIV preventionResilienceRuralStigmaSubstance use

Identifiers

PMID41148410
PMCPMC12908228

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.